15 papers
Nephrology focuses on understanding and treating the kidneys, the vital organs responsible for filtering waste from our blood and balancing fluids in the body. This dynamic field tackles everything from common issues like kidney stones and infections to complex chronic diseases that require lifelong management. As researchers push the boundaries of what we know about renal health, new discoveries emerge daily, offering hope for better treatments and prevention strategies.
At Gist.Science, we ensure these advancements reach everyone by curating the latest preprints directly from medRxiv. Our team processes every new submission in this category, transforming dense scientific findings into clear, plain-language summaries alongside detailed technical analyses. This dual approach allows both curious readers and medical professionals to stay informed without getting lost in complex jargon.
Below you will find the most recent preprints covering the latest breakthroughs and studies in kidney health and disease.
This study reconstructs the regulatory architecture of immune dysregulation in lupus nephritis by integrating single-cell multi-omics data with genetic analyses to identify cell-type-specific mechanisms, causal genes, and transcription factor networks that link genetic variation to disease pathogenesis.
This paper outlines a research protocol and baseline results for a prospective multi-regional study in Nicaragua, South India, and Sri Lanka aimed at identifying the environmental and occupational causes—specifically metals, agrochemicals, infections, and heat/dehydration—of the epidemic of Chronic Kidney Disease of unknown cause (CKDu) affecting agricultural communities in low-and-middle-income countries.
This study estimates that predicted pathogenic variants in genes associated with Autosomal Dominant Polycystic Liver Disease (ADPLD) occur in approximately 1 in 95 to 1 in 151 individuals within the general population, with higher frequencies observed in admixed American, Finnish, and African/African American groups compared to Europeans, despite the condition's variable penetrance and expressivity.
This systematic review and meta-analysis demonstrates that deep brain stimulation targeting the ventral intermediate nucleus of the thalamus consistently produces substantial tremor reduction across diverse targeting methodologies, despite significant heterogeneity in surgical approaches and study designs.
This study reveals significant variation in tolvaptan prescribing across UK kidney centers, where a substantial proportion of eligible patients with ADPKD remain untreated while many ineligible patients receive the therapy, leading to substantial potential losses in both healthcare costs and quality-adjusted life years.
This study proposes and validates a novel hybrid XGBoost-LSTM framework with temporal attention (XLA) that significantly outperforms traditional static models in predicting chronic kidney disease progression by leveraging longitudinal claims data to capture temporal disease trajectories, while also highlighting the critical limitation of cross-sectional features in the absence of direct UACR measurements.
This study identifies urinary myoglobin as a specific noninvasive biomarker for distinguishing CUBN-related chronic benign proteinuria (PROCHOB) from glomerular diseases, offering a diagnostic strategy that reduces unnecessary kidney biopsies and guides targeted genetic testing.
This study utilizes an XGBoost machine learning model to identify soil type, water pH, electrical conductivity, and fluoride concentration as key environmental predictors of Chronic Kidney Disease of unknown etiology (CKDu) in Sri Lanka, thereby highlighting the need for targeted water quality and agrochemical interventions to mitigate the disease's prevalence.
This Japanese cohort study of patients with chronic kidney disease or heart failure found that while physical quality of life was generally impaired, the use of potassium binders had a less negative impact on quality of life than dietary restrictions and supported the continued use of RAAS inhibitors.
This study demonstrates that medullary cast formation is an independent predictor of adverse kidney outcomes in chronic kidney disease patients and provides incremental prognostic value beyond conventional cortical pathology assessments.